The Journal of Law, Medicine & Ethics 2006: Vol 34 Index & Table of Contents

2006·0.9 MB·English

Index to Volume 3
Spring 2006, 34.1 Joan H. Krause, “The Ethical Health Lawyer,” pp.
Defining the Beginning and the End of Human Life: 121-125.
Implicatiofnosr Ethics, Policy, and Law Pamela Bush, “Reviews in Medical Ethics,” pp. 126-
Robert M. Sade, ed. 130.
Harvard Law and Health Care Society, “Recent Case
Symposium Articles Developments in Heath Law,’ pp. 131-138.
Robert M. Sade, “Introduction: Defining The Begin-
ning and The End of Human Life: Implications For
Ethics, Policy, and Law,’ pp. 6-7. Summer 2006, 34.2
Lynn M. Morgan, “Life Begins When They Steal DNA Fingerprinting and Civil Liberties
Your Bicycle’: Cross-Cultural Practices of Personhood Alice A. Noble and Benjamin W. Moulton, eds.
at the Beginnings and Ends of Life,” pp. 8-15.
Don Marquis, “Abortion and the Beginning and End Symposium Articles
of Human Life,” pp. 16-25. Mark A. Rothstein and Meghan K. Talbott, “The Ex-
Bonnie Steinbock, “The Morality of Killing Human panding Use of DNA in Law Enforcement: What Role
Embryos,’ pp. 26-34. for Privacy?” pp. 153-164. -
James L. Bernat, “The Whole-Brain Concept of Tracey Maclin, “Is Obtaining an Arrestee’s DNA a
Death Remains Optimum Public Policy,” pp. 35-43. Valid Special Needs Search Under the Fourth Amend-
Jeff McMahan, “An Alternative to Brain Death,” ment? What Should (and Will) the Supreme Court
pp.44-48. Do?” pp.165-187.
David DeGrazia, “Moral Status, Human Identity, D. H. Kaye, “Who Needs Special Needs? On the Con-
and Early Embryos: A Critique of the President’s Ap- stitutionality of Collecting DNA and Other Biometric
proach,” pp. 49-57. Data from Arrestees,” pp. 188-198.
George Khushf, “Owning up to our Agendas: On the Tania Simoncelli and Barry Steinhardt, “California’s
Role and Limits of Science in Debates About Embryos Proposition 69: A Dangerous Precedent for Criminal
and Brain Death,” pp. 58-76. DNA Databases,” pp. 199-213.
Amitai Etzioni, “A Communitarian Approach: A
Independent Articles Viewpoint on the Study of the Legal, Ethical and Policy
James G. Hodge, Jr., Lawrence O. Gostin, Kristine Considerations Raised by DNA Tests and Databases,”
Gebbie, and Deborah L. Erickson, “Transforming Pub- pp. 214-221.
lic Health Law: The Turning Point Model State Public Frederick R. Bieber, “Turning Base Hits into Earned
Health Act,” pp. 77-84. Runs: Improving the Effectiveness of Forensic DNA
David P. Fidler and Lawrence O. Gostin, “The New Data Bank Programs,” pp. 222-233.
International Health Regulations: An Historic Devel- Robin Williams and Paul Johnson, “Inclusiveness,
opment for International Law and Public Health,” pp. Effectiveness and Intrusiveness: Issues in the Devel-
85-94. oping Uses of DNA Profiling in Support of Criminal
Peter Clark, “Physician Participation In Executions: Investigations,” pp. 234-247.
Care Giver Or Executioner?” pp. 95-104. Henry T. Greely, Daniel P. Riordan, Nanibaa’ A. Gar-
Jennifer Gold, “Conflict over Conflicts of Interest: An rison, and Joanna L. Mountain, “Family Ties: The Use
Analysis of the New NIH Rules,’ pp. 105-110. of DNA Offender Databases to Catch Offenders’ Kin,”
Tia Powell, Commentary, “Face Transplant: Real and pp. 248-263.
Imagined Ethical Challenges,” pp. 111-115. Erica Haimes, “Social and Ethical Issues in the Use of
Familial Searching in Forensic Investigations: Insights
Columns from Family and Kinship Studies,” pp. 263-276.
Cheryl Erwin and Robert Philibert, “Currents in Pilar N. Ossorio, “About Face: Forensic Genetic Test-
Conten_porary Ethics,” pp. 116-120. ing for Race and Visible Traits,” pp. 277-292.
NANOTECHNOLOGY * WINTER 2006
Troy Duster, “Explaining Differential trust of DNA Columns
Forensic Technology: Grounded Assessment or Inex- Richard R. Sharp and Mark Yarborough, “Currents
plicable Paranoia?” pp. 293-300. in Contemporary Ethics,” pp. 460-464.
Mervyn L. Tano, “Interrelationships among Native David B. Resnik, “Reviews in Medical Ethics,” pp.
Peoples, Genetic Research, and the Landscape: Need 465-466.
for Further Research into Ethical, Legal, and Social
Issues,” pp. 301-309. Staff of the American Journal! of Law & Medicine, “Re-
Paul C. Giannelli, “Forensic Science,” pp. 310-319. cent Developments in Health Law,” pp. 467-474.
Margaret A. Berger, “The Impact of DNA Exonera-
tions on the Criminal Justice System,’ pp. 320-327.
Sheila Jasanoff, “Just Evidence: The Limits of Sci- Fall 2006, 34.3
ence in the Legal Process,” pp. 328-341. The Responsible Use of Racial and Ethnic Categories in
Gregory Carey and Irving I. Gottesman, “Genes and Biomedical Research: Where do We Go from Here?
Antisocial Behavior: Perceived versus Real Threats to Susan M. Wolf, ed.
Jurisprudence,’ pp. 342-351.
Bartha Maria Knoppers, Madelaine Saginur, and Symposium Articles
Howard Cash, “Ethical Issues in Secondary Uses of Susan M. Wolf, “Introduction: Debating the Use of
Human Biological Materials from Mass Disasters,” pp. Racial and Ethnic Categories in Research,” pp. 483-
352-365. 487.
David Lazer and Viktor Mayer-Schonberger, “Statu- Troy Duster, “Lessons From History: Why Race and
tory Frameworks for Regulating Information Flows: Ethnicity Have Played A Major Role in Biomedical
Drawing Lessons for the DNA Databanks from other Research,’ pp. 487-496.
Government Data Systems,” pp. 366-374. Mildred K. Cho, “Racial and Ethnic Categories in
R. E. Gaensslen, “Should Biological Evidence or DNA Biomedical Research: There is no Baby in the Bathwa-
be Retained by Forensic Science Laboratories After ter,” pp. 497-499.
Profiling? No, Except Under Narrow Legislatively- Raj Bhopal, “Race and Ethnicity: Responsible Use
Stipulated Conditions,” pp. 375-379. from Epidemiological and Public Health Perspectives,”
M. Dawn Herkenham, “Retention of Offender DNA pp. 500-507.
Samples Necessary to Ensure and Monitor Quality of Morris W. Foster, “Analyzing the Use of Race and
Forensic DNA Efforts: Appropriate Safeguards Exist to Ethnicity in Biomedical Research from a Local Com-
Protect the DNA Samples from Misuse,” pp. 380-384. munity Perspective,’ pp. 508-513.
Michael E. Smith, “Let’s Make the DNA Identifica- Rose M. Brewer, “Thinking Critically about Race and
tion “atabase as Inclusive as Possible,” pp. 385-389. Genetics,” pp. 513-519.
Tania Simoncelli, “Dangerous Excursions: The Case Margaret A. Winker, “Race and Ethnicity in Medical
against Expanding Forensic DNA Databases to Inno- Research: Requirements Meet Reality,’ pp. 520-525.
cent Persons,’ pp. 390-397. Dorothy E. Roberts, “Legal Constraints on the Use of
Lori Andrews, “Who Owns Your Body? A Patient’s Race in Biomedical Research: Toward a Social Justice
Perspective on Washington University v. Catalona,’ Framework,’ pp. 526-534.
pp. 398-407. Erik Lillquist and Charles Sullivan, “Legal Regula-
Sharon F, Terry and Patrick F. Terry, “A Consumer tions on the Use of Race in Medical Research,’ pp. 535-
Perspective on Forensic DNA Banking,” pp. 408-415. Dol.
Jay N. Cohn, “The Use of Race and Ethnicity in Med-
Independent Articles icine: Lessons from the African-American Heart Fail-
Gil Siegal and Richard J. Bonnie, “Closing the Organ ure Trial,” pp. 552-554.
Gap: A Reciprocity-Based Social Contract Approach,” M. Gregg Bloche, “Race, Money and Medicines,” pp.
pp. 415-423. 555-558.
Paul B. Miller and Charles Weijer, “Fiduciary Obliga-
tion in Clinical Research,” pp. 424-440. Independent Articles
Emily L. Evans and Alex John London, “Equipoise Roger S. Magnusson, “The Devil’s Choice: Re-Think-
and the Criteria for Reasonable Action,’ pp. 441-450. ing Law, Ethics and Symptom Relief in Palliative Care,”
Theresa O’Lonergan and John J. Zodrow, “Pediatric pp. 559-569.
Assent: Subject Protection Issues among Adolescent Peter A. Clark, “Medical Ethics at Guantanamo Bay
Females Enrolled in Research,’ pp. 451-459. and Abu Ghraib: The Problem of Dual Loyalty,” pp.
570-581.
834 JOURNAL OF LAW, MEDICINE & ETHICS
Kevin P. Weinfurt, Joélle Y. Friedman, Michaela A. Robin Wilson, “Nanotechnology: The Challenge of
Dinan, Jennifer S. Allsbrook, Mark A. Hall, Jatinder K. Regulating Known Unknowns,’ pp. 704-713.
Dhillon, and Jeremy Sugarman, “Disclosing Conflicts Gary E. Marchant and Douglas J. Sylvester, “Trans-
of Interest in Clinical Research: Views of Institutional national Models for Regulation of Nanotechnology,”
Review Boards, Conflict of Interest Committees, and pp. 714-725.
Investigators,” pp. 581-591. Bert Gordijn, “Converging NBIC Technologies for
Christine Grady, Elizabeth Horstmann, Jeffrey S. Improving Human Performance: A Critical Assess-
Sussman, and Sara Chandros Hull, “The Limits of Dis- ment of the Novelty and the Prospects of the Project,”
closure: What Research Subjects Want to Know About pp. 726-732.
Investigator Financial Interests,” pp. 592-599. Robert Best and George Khushf, “The Social Con-
Sadath A. Sayeed, “The Marginally Viable Newborn: ditions.of Nanomedicine: Disruption, Systems, and
Legal Challenges, Conceptual Inadequacies, and Rea- Lock-in,” pp. 733-740.
sonableness,” pp. 600-610. Calvin Shipbaugh, “Offense-Defense Aspects of Nan-
Ashok J. Bharucha, David Barnard, Alex John Lon- otechnologies: A Forecast of Potential Military Appli-
don, Howard Wactlar, Mary Amanda Dew, and Charles cations,” pp. 741-747.
F. Reynolds, “Ethical Considerations in the Conduct of
Electronic Surveillance Research,” pp. 611-619. Independent Articles
Rahul Rajkumar, Cary P. Gross, and Howard P. For-
Columns man, “Is the Tobacco Settlement Constitutional?” pp.
Barry DeCoster, “Currents in Contemporary Ethics,” 748-752.
pp. 620-623. Lainie Friedman Ross, “Heterozygote Carrier Testing
Robert Schwartz, “The Ethical Health Lawyer,’ pp. in High Schools Abroad: What are the Lessons for the
624-628. U.S.?” pp. 753-764.
Susan Herrick, “Reviews in Medical Ethics,” pp. 629- Jon S. Vernick, Daniel W. Webster, Maria T. Bulzac-
631. chelli, and Julie Samia Mair, “Regulation of Firearm
Harvard Law and Health Care Society, “Recent De- Dealers in the United States: An Analysis of State Law
velopments in Health Law,” pp. 6322 -646. and Opportunities for Improvement,” pp. 765-775.
Melinda Roberts, “Supernumerary Pregnancy, Col-
lective Harm, and Two Forms of the Nonidentity Prob-
lem,” pp. 776-792.
Nanotechnology Charles Weijer and Guy J. LeBlanc, “The Balm of
Robert Best, George Khushf, and Robin W. Wilson, Gilead: Is The Provision of Treatment to those Who Se-
ed. roconvert in HIV Prevention Trials a Matter of Moral
Obligation or Moral Negotiation?” pp. 793-808.
Symposium Articles
Robert Best, George Khushf, and Robin W. Wilson, Columns
“Introduction,” pp. 655-657. Amy L. McGuire and Richard A. Gibbs, “Currents in
Fabrice Jotterand, “The Politization of Science and Contemporary Ethics,” pp. 809-812.
Technology: Its Implications for Nanotechnology,’ pp. William Winslade and E. Bernadette McKinney,
658-666. “The Ethical Health Lawyer,’ pp. 813-816.
Mario Kaiser, “Drawing the Boundaries of Nanosci- Theodore W. Ruger, “Supreme Court Review,’ pp.
ence - Rationalizing the Concerns?” pp. 667-674. 817-820.
Ronald Sandler and W. D. Kay, “The National Nano- David Blazina, Erin Willoughby, and Robin Fretwell
technology Initiative and the Social Good,” pp. 675- Wilson, “Reviews in Medical Ethics,” pp. 821-825.
681. Erika Wilkinson, Katherine Polak and Daniel P.
Mark E. Meaney, “Lessons from the Sustainability Wilansky, “Recent Developments in Health Law,” pp.
Movement: Toward an Integrated Decision Making 826-832.
Framework for Nanotechnology,’ pp. 682-688. Index; pp. 833-835.
Alexei Grinbaum, “Cognitive Barriers in Perception
of Nanotechnology,’ pp. 689-694.
Ahson Wardak and Michael Gorman, “Using Trading
Zones and Life Cycle Analysis to Understand Nano-
technology Regulation,” pp. 695-703.
NANOTECHNOLOGY * WINTER 2006